St. Jude Medical (STJ) : Paradigm Asset Management Co reduced its stake in St. Jude Medical by 2.22% during the most recent quarter end. The investment management company now holds a total of 79,100 shares of St. Jude Medical which is valued at $6 Million after selling 1,800 shares in St. Jude Medical , the firm said in a disclosure report filed with the SEC on May 12, 2016.St. Jude Medical makes up approximately 1.12% of Paradigm Asset Management Co’s portfolio.
Other Hedge Funds, Including , Teacher Retirement System Of Texas boosted its stake in STJ in the latest quarter, The investment management firm added 3,912 additional shares and now holds a total of 498,693 shares of St. Jude Medical which is valued at $37.8 Million. St. Jude Medical makes up approx 0.26% of Teacher Retirement System Of Texas’s portfolio.Cibc Asset Management Inc boosted its stake in STJ in the latest quarter, The investment management firm added 577 additional shares and now holds a total of 28,696 shares of St. Jude Medical which is valued at $2.2 Million. St. Jude Medical makes up approx 0.02% of Cibc Asset Management Inc’s portfolio.Princeton Alpha Management Lp reduced its stake in STJ by selling 21,198 shares or 45.3% in the most recent quarter. The Hedge Fund company now holds 25,597 shares of STJ which is valued at $1.9 Million. St. Jude Medical makes up approx 0.31% of Princeton Alpha Management Lp’s portfolio.Nisa Investment Advisors L.l.c. boosted its stake in STJ in the latest quarter, The investment management firm added 10,890 additional shares and now holds a total of 76,695 shares of St. Jude Medical which is valued at $5.8 Million. St. Jude Medical makes up approx 0.08% of Nisa Investment Advisors L.l.c.’s portfolio.
St. Jude Medical opened for trading at $76.62 and hit $76.84 on the upside on Friday, eventually ending the session at $76.78, with a gain of 0.76% or 0.58 points. The heightened volatility saw the trading volume jump to 40,92,199 shares. Company has a market cap of $21,827 M.
On the company’s financial health, St. Jude Medical reported $0.90 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $0.88. The company had revenue of $1448.00 million for the quarter, compared to analysts expectations of $1437.78 million. The company’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.
Investors should note that on May 4, 2016, St. Jude Medical announced a cash dividend of $0.3100. The company’s management has announced Jun 28, 2016 as the ex-dividend date and fixed the record date on Jun 30, 2016. The payable date has been fixed on Jul 29, 2016.
Many Wall Street Analysts have commented on St. Jude Medical. St. Jude Medical was Downgraded by Sun Trust Rbsn Humphrey to ” Neutral” on May 10, 2016. St. Jude Medical was Downgraded by Credit Suisse to ” Neutral” on May 3, 2016. St. Jude Medical was Downgraded by Morgan Stanley to ” Equal-Weight” on May 2, 2016.
St. Jude Medical Inc. develops manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management cardiovascular and atrial fibrillation therapy areas and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems bradycardia pacemaker systems atrial fibrillation (AF) products (electrophysiology introducers and catheters advanced cardiac mapping navigation and recording systems and ablation systems) vascular products (vascular closure products pressure measurement guidewires optical coherence tomography (OCT) imaging products heart failure monitoring device and other vascular accessories) structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).